Position in AMLX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$31,435,808
+$16,938,650 QoQ
Shares Held
2,261,569
+88.4% QoQ
Ownership
2.03%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $555,929,631 across 34 Drug Manufacturers - Specialty & Generic names. AMLX ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
277,983 | $164,838,356 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
611,264 | $80,527,917 | |
| 3 | VTRS |
Viatris Inc
|
5,569,529 | $75,244,331 | |
| 4 | ZTS |
Zoetis Inc.
|
569,669 | $67,340,568 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
2,856,094 | $39,556,900 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
2,261,569 | $31,435,808 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
732,290 | $22,056,572 | |
| 8 | HLN |
Haleon plc
|
1,525,032 | $15,265,566 |
All Filings in AMLX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,435,808 | 2,261,569 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $14,497,158 | 1,200,096 | Shares | Defined | 2026-02-11 | |
| 2024-03-31 | $5,270,716 | 1,855,886 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $19,504,014 | 1,325,001 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $11,313,144 | 617,867 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $614,442 | 28,486 | Shares | Defined | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||